Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

This study has been terminated.

(Parent protocol (SWOG S0816 / AMC-073) discontinued)

Sponsor:

Collaborators:

National Cancer Institute (NCI)

The EMMES Corporation

Information provided by (Responsible Party):

AIDS Malignancy Consortium

ClinicalTrials.gov Identifier:

NCT01319526

First received: December 18, 2010

Last updated: October 1, 2015

Last verified: October 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2013
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)